Understand the source comparison
Peptide Protocol Comparison — Research Dosing and Mechanisms
BPC-157 Stimulates VEGF, promotes angiogenesis, accelerates enterocyte repair 250–500 mcg daily Oral or subcutaneous 4–6 hours Most direct mucosal repair compound. Oral for localised gut contact, SC for systemic effects KPV Inhibits NF-kB translocation, reduce
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- BPC-157
- Stimulates VEGF, promotes angiogenesis, accelerates enterocyte repair
- 250–500 mcg daily
- Oral or subcutaneous
- 4–6 hours
- Most direct mucosal repair compound. Oral for localised gut contact, SC for systemic effects
- KPV
- Inhibits NF-kB translocation, reduces TNF-alpha and IL-6 in gut tissue
- 500 mcg–2 mg daily
- Subcutaneous
- 2–4 hours
- Potent anti-inflammatory in IBD models. Addresses cytokine-driven barrier dysfunction
- Thymalin
- Upregulates regulatory T-cells, modulates autoimmune gut inflammation
- 5–10 mg per cycle (10 days)
- Subcutaneous or intramuscular
- 6–8 hours
- Indirect repair through immune modulation. Best for autoimmune-driven permeability